secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001104659-24-104541
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics furnishes investor presentation on amyloid beta oligomer approach
--------------------------------------------------------------------------------

- Presentation titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of CNS Disorders' dated September 2024 made available.
- No specific financial results, clinical data, or guidance changes disclosed in filing or exhibit.
- Presentation furnished for Regulation FD; not incorporated by reference into SEC filings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/0001104659-24-104541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/tm2425259d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-104541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer